Obstetrx
Wilsonville, US · Founded 2017 · Delaware corporation
Find your way into Obstetrx
Sign up to see every warm intro you have to Obstetrx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Obstetrx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Obstetrx develops a uterine tamponade medical device to control postpartum hemorrhage, adapting hemorrhage-control technology originally created for battlefield trauma. The company is working toward regulatory clearance and commercialization of the device in the US and globally, addressing women's health.
Founders & leadership
AB
Andrew BarofskyNamed on SEC filing
KG
Kenton GregoryNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 1 round · 2021
▶$1.1MraisedAug 2021 · 1 investors · Other Health CareRule 506(b)
▶$1.1MraisedAug 2021 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Andrew BarofskyExecutive Officer, Director
- Kenton GregoryDirector
- Offering amount
- $3M
- Amount sold
- $1.1M
- Minimum investment
- $500K
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
RevMedxRevMedx develops hemorrhage-control medical devices, including the XSTAT expanding-sponge injector for junctional bleeding, ratcheting TX tourniquets, and compression wraps. Its products serve licensed medical professionals, first responders, and military users such as US Special Operations Forces.
DigitalDigital Trends is a consumer technology media outlet that publishes news, reviews, and buying guides covering gadgets, electronics, software, AI, automobiles, and entertainment. It serves general consumers looking for product recommendations and coverage of tech industry developments.
MicAugust is a sustainable period-care brand that sells tampons, pads, and liners with plastic-free, dissolvable wrappers, positioning itself through direct-to-consumer marketing that uses explicit period imagery and avoids euphemisms to challenge menstrual stigma. The company serves people who menstruate and emphasizes both environmental impact reduction and period education.
Companies working in the same space as Obstetrx.
Frequently asked questions
- What does Obstetrx do?
- Obstetrx develops a uterine tamponade medical device to control postpartum hemorrhage, adapting hemorrhage-control technology originally created for battlefield trauma. The company is working toward regulatory clearance and commercialization of the device in the US and globally, addressing women's health.
- How much funding has Obstetrx raised?
- Obstetrx has disclosed $1.1M raised across 1 round.
- Where is Obstetrx headquartered?
- Obstetrx is headquartered in Wilsonville, US.
